Management of acute ischemic stroke

F Herpich, F Rincon - Critical care medicine, 2020 - journals.lww.com
Objectives: Concise “synthetic” review of the state of the art of management of acute
ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We …

Ischaemic stroke

BCV Campbell, DA De Silva, MR Macleod… - Nature reviews Disease …, 2019 - nature.com
Stroke is the second highest cause of death globally and a leading cause of disability, with
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …

European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

E Berge, W Whiteley, H Audebert… - European stroke …, 2021 - journals.sagepub.com
Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint …

CE Kvistad, H Næss, BH Helleberg, T Idicula… - The Lancet …, 2022 - thelancet.com
Background Tenecteplase is a modified tissue plasminogen activator with pharmacological
and practical advantages over alteplase—which is currently the only approved thrombolytic …

Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a …

WJ Powers, AA Rabinstein, T Ackerson, OM Adeoye… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations in a single document for clinicians caring for adult …

Management of acute ischemic stroke

MS Phipps, CA Cronin - Bmj, 2020 - bmj.com
Stroke is the leading cause of long term disability in developed countries and one of the top
causes of mortality worldwide. The past decade has seen substantial advances in the …

Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open …

A Bivard, H Zhao, L Churilov, BCV Campbell… - The Lancet …, 2022 - thelancet.com
Summary Background Mobile stroke units (MSUs) equipped with a CT scanner reduce time
to thrombolytic treatment and improve patient outcomes. We tested the hypothesis that …

2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association …

WJ Powers, AA Rabinstein, T Ackerson, OM Adeoye… - stroke, 2018 - Am Heart Assoc
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A
Guideline for Healthcare Professionals From the American Heart Association/American Stroke …

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

N Logallo, V Novotny, J Assmus, CE Kvistad… - The Lancet …, 2017 - thelancet.com
Background Tenecteplase is a newer thrombolytic agent with some pharmacological
advantages over alteplase. Previous phase 2 trials of tenecteplase in acute ischaemic stroke …

The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy

R von Kummer, JP Broderick, BCV Campbell… - Stroke, 2015 - Am Heart Assoc
2982 Stroke October 2015 threshold between PH1 and PH2 was not clarified. 10
Regardless, in the ECASS, only PH2, but not PH1 or HI, was associated with early …